VIRALYTICS LTD SPON ADR EACH REPR 3 (NASDAQ:VRACY) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.

Zacks has also assigned VIRALYTICS LTD SPON ADR EACH REPR 3 an industry rank of 92 out of 265 based on the ratings given to related companies.

VIRALYTICS LTD SPON ADR EACH REPR 3 (NASDAQ:VRACY) remained flat at $2.08 on Tuesday. VIRALYTICS LTD SPON ADR EACH REPR 3 has a 12-month low of $0.74 and a 12-month high of $1.95. The firm’s market cap is $166.33 million. The firm’s 50-day moving average price is $1.49 and its 200-day moving average price is $1.44.

About VIRALYTICS LTD SPON ADR EACH REPR 3

5 Day Chart for NASDAQ:VRACY

Get a free copy of the Zacks research report on VIRALYTICS LTD SPON ADR EACH REPR 3 (VRACY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for VIRALYTICS LTD SPON ADR EACH REPR 3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VIRALYTICS LTD SPON ADR EACH REPR 3 and related companies with Analyst Ratings Network's FREE daily email newsletter.